skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

2 Total results for product and free and sample content found

Scrip

Mortality Signal For Pfizers Xeljanz In Rheumatoid Arthritis Puts A Damper On JAK Class

By Emily Hayes 21 Feb 2019

Analyst speculates that risk of pulmonary embolism for a higher unapproved of Xeljanz in arthritis could trigger a label change for the same regimen in the drug's ulcerative colitis indication.

Topic Arthritis

Datamonitor Healthcare

An exploration Rheumatoid Arthritis overview

13 Sep 2017

Despite key markets pressures, the rheumatoid arthritis (RA) market is forecast to continue to grow over the next 10 years. Our RA coverage highlights where the opportunities remain, with a detailed look into the future of the RA treatment.

Topic Arthritis

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: